You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Urothelial Cancer

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Urothelial Carcinoma, Urothelial Carcinoma Recurrent, Urothelial Carcinoma Ureter Trial (Jelmyto (mitomycin) for pyelocalyceal

Not yet recruiting
  • Urothelial Carcinoma
  • +7 more
  • Jelmyto (mitomycin) for pyelocalyceal solution
  • (no location specified)
May 22, 2023

Advanced Urothelial Carcinoma Trial in Beijing (9MW2821, Toripalimab)

Not yet recruiting
  • Advanced Urothelial Carcinoma
  • Beijing, Beijing, China
    Beijing Cancer Hospital
Oct 9, 2023

Metastatic Urothelial Carcinoma Trial in Québec (Bicalutamide 150 mg, Placebo)

Not yet recruiting
  • Metastatic Urothelial Carcinoma
  • Bicalutamide 150 mg
  • Placebo
  • Québec, Canada
    CHU de Québec - Université Laval
Sep 6, 2023

Urothelial Cancer and Rare Genitourinary Tract Malignancies

Recruiting
  • Urothelial Cancer
  • +4 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Jan 23, 2023

    HER2 and LA/mUC: A Multi-country Chart Review Cohort Study

    Not yet recruiting
    • Urothelial Carcinoma
      • (no location specified)
      Jun 5, 2023

      Urothelial Carcinoma Ureter, Urothelial Cancer of Renal Pelvis Trial (Mitomycin C)

      Not yet recruiting
      • Urothelial Carcinoma Ureter
      • Urothelial Cancer of Renal Pelvis
      • Mitomycin C
      • (no location specified)
      Jul 31, 2023

      Metastatic Cancer, Metastatic Colorectal Cancer, Metastatic Pancreatic Cancer Trial (OB-002)

      Not yet recruiting
      • Metastatic Cancer
      • +5 more
      • (no location specified)
      Jul 10, 2023

      Urothelial Cancer Trial in Beijing (Atezolizumab, RO7247669, Tiragolumab)

      Recruiting
      • Urothelial Cancer
      • Beijing, China
        Beijing Cancer Hospital
      Jan 18, 2023

      High Grade Urothelial Carcinoma, Bladder Cancer, Urothelial Carcinoma Bladder Trial in Washington, Baltimore (Enfortumab

      Not yet recruiting
      • High Grade Urothelial Carcinoma
      • +2 more
      • Washington, District of Columbia
      • +1 more
      Jan 5, 2023

      Care of Urothelial Cancer Patient and Prospective Procurement of

      Recruiting
      • Bladder Cancer
      • +3 more
        • Bethesda, Maryland
          National Institutes of Health Clinical Center, 9000 Rockville Pi
        Aug 24, 2022

        Urothelial Carcinoma Trial (Avelumab)

        Not yet recruiting
        • Urothelial Carcinoma
        • (no location specified)
        Oct 26, 2022

        Bladder Urothelial Carcinoma, Urothelial Carcinoma Trial in Philadelphia (Copper Cu 64 TP3805, Positron Emission Tomography,

        Active, not recruiting
        • Bladder Urothelial Carcinoma
        • Urothelial Carcinoma
        • Copper Cu 64 TP3805
        • +2 more
        • Philadelphia, Pennsylvania
          Sidney Kimmel Cancer Center at Thomas Jefferson University
        Dec 13, 2022

        Urothelial Carcinoma Trial (disitamab vedotin, pembrolizumab, gemcitabine)

        Not yet recruiting
        • Urothelial Carcinoma
        • disitamab vedotin
        • +4 more
        • (no location specified)
        Jun 9, 2023

        Adults in South Korea With Cancer Who Receive PADCEV Injection

        Recruiting
        • Urothelial Cancer
        • Enfortumab Vedotin
        • Seoul, Korea, Republic of
          KR82004
        Aug 22, 2023

        Avelumab in Real-World Treatment for Advanced or Metastatic

        Not yet recruiting
        • Bladder Cancer
        • (no location specified)
        Nov 21, 2022

        Urothelial Cancer Trial (pembrolizumab)

        Completed
        Has Results
        • Urothelial Cancer
        • pembrolizumab
        • (no location specified)
        Aug 18, 2022

        Advanced or Metastatic Urothelium Cancer Trial in Beijing (MRG002, Docetaxel Injection, Paclitaxel Injection)

        Not yet recruiting
        • Advanced or Metastatic Urothelium Cancer
        • Beijing, Beijing, China
          Cancer Hospital Chinese Academy of Medical Sciences
        Feb 22, 2023

        Urothelial Carcinoma Trial in Iowa City (Avelumab, Docetaxel)

        Active, not recruiting
        • Urothelial Carcinoma
        • Iowa City, Iowa
          University of Iowa Hospitals and Clinics
        Oct 18, 2022

        Tumor Trial in China, Korea, Republic of, Taiwan (Erdafitinib)

        Active, not recruiting
        • Neoplasm
        • Beijing, China
        • +5 more
        Jan 31, 2023

        Physical and Biological Effects of Upper Tract Urothelial Cancer

        Recruiting
        • Upper Tract Urothelial Cancer
          • Hong Kong, Hong Kong
            Prince of Wales Hospital
          Jun 29, 2022

          Urothelial Carcinoma, Metastatic Urothelial Carcinoma, Locally Advanced Urothelial Carcinoma Trial in Philadelphia (Enfortumab

          Not yet recruiting
          • Urothelial Carcinoma
          • +2 more
          • Philadelphia, Pennsylvania
            Fox Chase Cancer Center - Philadelphia
          Jun 27, 2023

          Urogenital Cancer Trial in London (Atezolizumab)

          Recruiting
          • Urogenital Cancer
          • London, United Kingdom
            Barts and London Hospital NHS Trust
          Aug 10, 2022

          Urothelial Carcinoma Trial in United States (Atezolizumab, Bevacizumab)

          Terminated
          • Urothelial Carcinoma
          • Phoenix, Arizona
          • +7 more
          Dec 15, 2022

          Urothelial Carcinoma Trial in Amsterdam, Nijmegen (Nivolumab)

          Recruiting
          • Urothelial Carcinoma
          • Amsterdam, Netherlands
          • +1 more
          Jul 28, 2022

          Metastatic Urothelial Cancer in Latin America

          Completed
          • Recurrent/Metastatic Urothelial Cancers
            • Salvador, BA, Brazil
            • +8 more
            Sep 26, 2022